This is weird....
Mayne Pharma swung to an interim net loss of $173 million, from a profit of $71.3 million a year ago.
The result was hit by asset impairments, restructuring expenses and restatement of deferred tax assets and liabilities following a reduction in the US corporate tax rate.
Revenue fell by 17.5 per cent to $243.3 million and the company didn't declare an interim dividend.
And they are up 6%?! haha
This is weird.... Mayne Pharma swung to an interim net loss of...
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
